Tilray Brands, Inc. (ETR:2HQ)
Germany
· Delayed Price · Currency is EUR | Market Cap | 966.29M |
| Revenue (ttm) | 723.82M |
| Net Income (ttm) | -1.93B |
| Shares Out | n/a |
| EPS (ttm) | -2.17 |
| PE Ratio | n/a |
| Forward PE | 29.78 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 137,981 |
| Average Volume | 130,739 |
| Open | 1.0060 |
| Previous Close | 1.0350 |
| Day's Range | 0.9274 - 1.1010 |
| 52-Week Range | 0.2804 - 1.8000 |
| Beta | 1.95 |
| RSI | 82.65 |
| Earnings Date | Jul 29, 2025 |
About Tilray Brands
Tilray Brands, Inc., a lifestyle consumer products company, engages in the research, cultivation, processing, and distribution of medical cannabis products in Canada, the United States, Europe, the Middle East, Africa, and internationally. The company operates through four segments: Beverage, Cannabis, Distribution, and Wellness. It also offers medical and adult-use cannabis products; resells and distributes pharmaceutical and wellness products; and produces, markets, and sells beverage products, and hemp-based food products. In addition, the c... [Read more]
Financial Performance
In 2025, Tilray Brands's revenue was $821.31 million, an increase of 4.10% compared to the previous year's $788.94 million. Losses were -$2.19 billion, 792.6% more than in 2024.
Financial numbers in USD Financial StatementsNews
Tilray Brands Reconfirms Strategy to Regain Nasdaq Compliance; Requests Extension to Meet Listing Requirements
NEW YORK and LEAMINGTON, Ontario, Aug. 14, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc. (“Tilray” or the “Company”) (Nasdaq: TLRY; TSX: TLRY), a global lifestyle consumer packaged goods company at the...
What's Going On With Tilray Brands Stock Today?
European pharmaceutical landscapes are rapidly evolving, unlocking new alliances and opportunities for innovative medical treatments. Tilray Brands, Inc. (NASDAQ: TLRY) shares are trading higher on W...
Tilray Medical Forms Strategic Partnership in Italy to Broaden Access to Medical Cannabis Extracts
Tilray's FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on Pain and Substance Dependence Therapies Tilray's FL Group Teams Up with Molteni, a Major Pharmaceutical Firm Focused on ...
What's Going On With Tilray Stock Today?
Tilray Brands, Inc. (NASDAQ: TLRY) shares are trading higher on Tuesday. Shares of the medical and recreational cannabis producer traded higher Tuesday as President Donald Trump recently said his adm...
Is Tilray stock price rally a trap? history suggests selling
Tilray Brands stock price has gone vertical this week, joining other cannabis companies like Canopy Growth, Curaleaf, and Truelive. TLRY surged to a high of $1.06, its highest level since February, an...
Tilray Expands Hemp-Derived Delta-9 THC Beverage Lineup with 10mg Drinks from Fizzy Jane's and Happy Flower Brands
NEW YORK, Aug. 12, 2025 (GLOBE NEWSWIRE) -- Tilray Brands, Inc . (“Tilray”) (NASDAQ: TLRY and TSX: TLRY) is building on the momentum of its hemp-derived Delta-9 THC (HDD9) beverage portfolio with new ...
Tilray Brands: Is TLRY Stock The Next Big Thing?
Tilray Brands (NASDAQ:TLRY), a pharmaceutical company that focuses on the production and distribution of medical and adult-use cannabis, craft beer, spirits, beverages, and hemp foods, offers an intri...
Tilray Surges 14% After Hours On Trump Cannabis Reclassification
Tilray Brands Inc. (NASDAQ: TLRY) stock surged by 14.13%, to $1.05 during after-hours on Monday. This surge follows a report suggesting that President Donald Trump is contemplating reclassifying mari...
BigBear.ai, Tilray Brands, AMC, AST SpaceMobile And Intel: Why These 5 Stocks Are On Investors' Radars Today
U.S. stocks closed lower on Monday, with the Dow Jones Industrial Average slipping 0.45% to 43,975.09. The Nasdaq fell 0.3% to 21,385.40, and the S&P 500 declined 0.25% to 6,373.45. These are the top ...
Cannabis stocks rally after Trump says he is weighing drug reclassification
Cannabis stocks rallied Monday after President Donald Trump said he is considering reclassifying marijuana, which would categorize it as less of a danger to public safety.
Cannabis stocks soar on Trump reclassification speculation
Following a Wall Street Journal report, cannabis stocks surged Monday due to speculation that US President Donald Trump is considering reclassifying marijuana to a lower danger level. Canopy Growth an...
Cannabis stocks rally on Wall Street Journal report that Trump is weighing drug reclassification
Cannabis stocks rallied on a Wall Street Journal report that President Donald Trump is contemplating reclassifying weed as having a lower danger level. Such a move would be "a gamechanger" for the ind...
Best Canadian Cannabis Penny Stocks Under $5 to Watch Now
The U.S. cannabis industry remains a high-growth sector, valued at over $34 billion in 2024. Experts project it could reach $57 billion by 2030. Despite short-term volatility, marijuana penny stocks c...
Tilray Brands Launches The Humble Seed Whole Wheat Protein Crackers at Whole Foods Market
NEW YORK and WINNIPEG, Manitoba, Aug. 07, 2025 (GLOBE NEWSWIRE) -- The Humble Seed, a better-for-you snack brand from Tilray Wellness a subsidiary of Tilray Brands, Inc. (“Tilray”) (NASDAQ: TLRY; TSX:...
Tilray Brands Is A Buy Again
Tilray's Unique Strategy Could Make It A Winner As Cannabis, Beverages, And Wellness Mature
Investor interest in cannabis stocks has cooled since the legalization boom of 2021, and the craft beer and wellness sectors have had their own struggles navigating changing consumer tastes. But Tilra...
Tilray's Unique Strategy Could Make It A Winner As Cannabis, Beverages, And Wellness Mature
Investor interest in cannabis stocks has cooled since the legalization boom of 2021, and the craft beer and wellness sectors have had their own struggles navigating changing consumer tastes. But Tilra...
Is Tilray Brands a Dirt Cheap Growth Stock or Just a Bad Buy?
Shares of the cannabis producer have been rallying, but they are still nowhere near the levels they were at a few years ago.
Cannabis Stocks Are at a Turning Point: Is Now the Time to Invest?
Currently, the cannabis industry is in another transitional period, presenting both challenges and potential opportunities for investors. After several years of volatility and downward trading, mariju...
Tilray Brands Reports In-Line Q4-2025 And FY2025 Results Amidst Weakening Sector
Tilray Brands, Inc. (TLRY) Q4 2025 Earnings Call Transcript
Tilray Q4 Results Show Major Problems
Tilray's fiscal Q4 results disappointed, with revenues missing estimates and a massive $1.26 billion net loss driven by impairment charges. TLRY's ongoing cash burn has resulted in tremendous sharehol...
Tilray Misses Q4 Revenue, Beats EPS Estimates, Shares Slide
Tilray Brands Inc (NASDAQ: TLRY) reported fourth-quarter financial results for fiscal 2025 after the market close on Monday. Here’s a rundown of the report . TLFY stock is volatile after hours. Check...
Tilray Brands Reports Fourth Quarter and Fiscal 2025 Financial Results
Fiscal Year Net Revenue of $821 Million, $834 Million in Constant Currency, Strategic Decisions Impacted Revenue by $35 Million
A Peek at Tilray Brands's Future Earnings
Tilray Brands (NASDAQ: TLRY) is set to give its latest quarterly earnings report on Monday, 2025-07-28. Here's what investors need to know before the announcement. Analysts estimate that Tilray Brand...